Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2021 October;112(5) > Minerva Medica 2021 October;112(5):542-6

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  ASTHMA AND SEVERE ASTHMA MANAGEMENT IN THE CLINICAL PRACTICE 

Minerva Medica 2021 October;112(5):542-6

DOI: 10.23736/S0026-4806.21.07281-5

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Epidemiology of severe asthma and international register

Elena TAGLIABUE , Elisa TRUCCO, Fulvio BRAIDO

Department of Internal Medicine and Medical Specialties, Clinic of Respiratory Disease and Allergology, University of Genoa, Genoa, Italy



Severe asthma (SA) in an asthma that requires therapy with high dose inhaled corticosteroids with a second controller, or oral corticosteroids, to ensure that it does not become “uncontrolled,” or that it does not respond to appropriate therapy. Severe asthma has a great impact on quality of life. There is a great heterogeneity of this disease, not only from a clinical point of view, but also from a functional and pathophysiological one. It is really hard to identify specific characteristics that identify this subgroup. Specific registers of SA, both national and international, are really important to describe the epidemiological characteristics of the disease and to analyze the clinical characteristics of the various subgroups of patients. This is an excellent starting point to be able to investigate the characteristics of the disease in detail.


KEY WORDS: Asthma; Registries; Epidemiology

top of page